Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin
- PMID: 15004089
- PMCID: PMC356858
- DOI: 10.1128/JCM.42.3.1263-1264.2004
Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin
Abstract
Resistance of group B streptococcus (GBS) to antibiotics, particularly erythromycin and clindamycin, was studied. Erythromycin resistance was present in 22% of GBS isolates, and these isolates were constitutively resistant, inducibly resistant, or sensitive to clindamycin. Erythromycin and clindamycin MICs were related to the presence of ermA, ermB, or mefA genes.
References
-
- American Academy of Pediatrics, Committee on Infectious Diseases, Committee on Fetus and Newborn. 1997. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 99:489-496. - PubMed
-
- American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. 1996. Prevention of early-onset group B streptococcal disease in newborns. Opinion 173. American College of Obstetricians and Gynecologists, Washington, D.C. - PubMed
-
- Centers for Disease Control and Prevention. 2002. Prevention of perinatal group B streptococcal disease. Morb. Mortal. Wkly. Rep. 51:1-22.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical